Operating Lease, Liability in USD of Lineage Cell Therapeutics, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Lineage Cell Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2018 to Q3 2025.
Lineage Cell Therapeutics, Inc. Operating Lease, Liability for the quarter ending September 30, 2025 was $2.54M, a 2.98% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Lineage Cell Therapeutics, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$2.54M	-$78K	-2.98%	Sep 30, 2025	10-Q	2025-11-06
Q2 2025	$2.06M	-$781K	-27.5%	Jun 30, 2025	10-Q	2025-08-12
Q1 2025	$2.14M	-$989K	-31.6%	Mar 31, 2025	10-Q	2025-05-13
Q4 2024	$2.39M	-$417K	-14.8%	Dec 31, 2024	10-Q	2025-11-06
Q3 2024	$2.62M			Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$2.84M			Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$3.13M			Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$2.81M	-$967K	-25.6%	Dec 31, 2023	10-K	2025-03-10
Q4 2022	$3.78M			Dec 31, 2022	10-K	2024-03-07
Q2 2022	$2.05M			Jun 30, 2022	10-Q	2022-08-11
Q4 2020	$242K	-$590K	-70.9%	Dec 31, 2020	10-K	2021-03-11
Q4 2019	$832K	-$1.17M	-58.4%	Dec 31, 2019	10-K	2021-03-11
Q3 2019	$5.19M			Sep 30, 2019	10-Q	2019-11-12
Q2 2019	$4.75M			Jun 30, 2019	10-Q	2019-08-08
Q1 2019	$4.94M			Mar 31, 2019	10-Q	2019-05-09
Q4 2018	$2M			Jan 2, 2019	10-Q	2019-11-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.